Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-22933

Xla Wt + chrd MO + nog MO, Rankin SA et al. (2011)

Experiment + Assay: Xla Wt + chrd MO + nog MO + NF33/34-35 and 36 (morphology)
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection chrd.1 MO1 chrd.S
chrd.L
 NF stage 2 (2-cell) blastomere
morpholino injection chrd.1 MO2 chrd.S
chrd.L
 NF stage 2 (2-cell) blastomere
morpholino injection nog MO1 nog.L
nog.S
 NF stage 2 (2-cell) blastomere
Conditions:
Assay Type Assay Stages Antibody
morphology NF stage 33 and 34 to NF stage 35 and 36  
Anatomical Phenotypes: abnormally posterioralized embryo, abnormally ventralized embryo
Source: fig.S1
Article: XB-ART-42631, PubMed